Suppliers / Sichuan Duorui Biopharmaceutical

Sichuan Duorui Biopharmaceutical

China Updated 9 July 2026

Sichuan Duorui Biopharmaceutical is an API manufacturer based in China. It holds 3 active US drug master files across a filed portfolio of 3 molecules.

3
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Lanreotide US FDA 1
Semaglutide US FDA 1
Tirzepatide US FDA 1

Also appears on these molecule pages

Lanreotide API Semaglutide API Tirzepatide API

Questions about Sichuan Duorui Biopharmaceutical

Does Sichuan Duorui Biopharmaceutical hold a US DMF or a CEP?
Sichuan Duorui Biopharmaceutical holds 3 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Sichuan Duorui Biopharmaceutical make?
3 molecules are on record against Sichuan Duorui Biopharmaceutical, including Lanreotide, Semaglutide and Tirzepatide. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Sichuan Duorui Biopharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Dr Reddy's Laboratories shares 1 molecule Piramal Pharma shares 1 molecule Alp Pharm Beijing shares 1 molecule Bcn Peptides shares 1 molecule Sinopep-Allsino Biopharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability